Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome — Stella

Home/Metabolic Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to Metabolic Syndrome trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Kazakhstan

Kuat Pernekulovich Oshakbayev, Astana, Astana

Key details

Phase

Post-approval study

Sponsor

University Medical Center, Kazakhstan

Collaborators

Nazarbayev University School of Medicine, Nazarbayev University

Enrollment target

~220 participants

Started

March 2024

Primary completion

September 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

35 Years – 65 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.